Oct 7, 2026· Comment from Association for Accessible Medicines and the Biosimilars Council· FDA-2026-D-4272-0009
Comments of the Association for Accessible Medicines and the Biosimilars Council.
Association for Accessible Medicines filed 1 comment on this docket between Oct 7, 2026 and Oct 7, 2026. 3 other organizations filed here.
Comments of the Association for Accessible Medicines and the Biosimilars Council.
No abstract recorded.
View on regulations.gov →